| Literature DB >> 28060949 |
Leonie A Krops1, Eva A Jaarsma1, Pieter U Dijkstra1,2, Jan H B Geertzen1, Rienk Dekker1,3.
Abstract
PURPOSE: To establish reference values for Health Related Quality of Life (HRQoL) in a Dutch rehabilitation population, and to study effects of patient characteristics, diagnosis and physical activity on HRQoL in this population.Entities:
Mesh:
Year: 2017 PMID: 28060949 PMCID: PMC5217970 DOI: 10.1371/journal.pone.0169169
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the participants and non-participants.
| Participants (n = 1223) | Non-participants (n = 1946) | Difference (95% CI) | p-value | |
|---|---|---|---|---|
| Mean±SD | Mean±SD | |||
| Age (years) | 53.9±14.3 | 49.1±15.6 | -4.8 (-5.9; -3.8) | <0.001 |
| Follow up (months) | 29.1±10.5 | 29.5±10.5 | 0.4 (-0.4; 1.1) | 0.317 |
| n (%) | n (%) | |||
| Gender (men) | 609 (50) | 931 (48) | 0.365 | |
| <0.001 | ||||
| Amputation | 49 (4) | 77 (4) | ||
| Brain injury | 418 (34) | 564 (29) | ||
| Chronic pain | 334 (27) | 664 (34) | ||
| Multiple sclerosis | 73 (6) | 98 (5) | ||
| Spinal cord injury | 98 (8) | 67 (3) | ||
| Other neurological disabilities | 99 (8) | 214 (11) | ||
| Other disabilities | 152 (12) | 270 (14) |
* significant difference between participants and non-participants
a Brain injuries from vascular, traumatic or oncological origin and meningitis
b Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome
c Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer.
Difference in HRQoL between the current rehabilitation population and a healthy Dutch reference population [40].
| Rehabilitation | Healthy | Difference | 95% CI | t-value | p-value | |
|---|---|---|---|---|---|---|
| PF | 51.6±31.7 | 81.9±23.2 | -30.3 | 28.03; 32.57 | 25.68 | <0.001 |
| SF | 64.6±27.1 | 86.9±20.5 | -22.3 | 20.34; 24.26 | 21.92 | <0.001 |
| RP | 43.1±40.6 | 79.4±35.5 | -36.3 | 33.11; 39.49 | 22.20 | <0.001 |
| RE | 70.5±40.8 | 84.1±32.3 | -13.6 | 10.53; 16.67 | 8.62 | <0.001 |
| MH | 65.2±15.1 | 76.8±18.4 | -11.6 | 10.21; 12.99 | 16.52 | <0.001 |
| VT | 52.1±16.6 | 67.4±19.9 | -15.3 | 13.78; 16.82 | 19.99 | <0.001 |
| BP | 65.2±26.6 | 79.5±25.6 | -14.3 | 12.16; 16.44 | 13.03 | <0.001 |
| GH | 54.7±21.1 | 72.7±22.7 | -18.0 | 16.19; 19.81 | 19.61 | <0.001 |
| HC | 51.2±24.3 | 52.4±19.4 | -1.2 | -0.60; 3.00 | 1.29 | 0.197 |
a mean±SD
b Results of a Dutch reference population [40]; PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change; 95% CI = 95% confidence interval
Fig 1Health related quality of life in rehabilitation and healthy individuals [40].
Dotted line = rehabilitation patients; solid line = healthy reference population [40]. Asterisks indicate significant differences between the rehabilitation patients and healthy individuals. PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change.
Results of the multiple regression analyses for all nine subscales of the RAND-36.
| Subscale | Predictor | Coëfficiënt (SE) | 95% CI | p-value | R2 change |
|---|---|---|---|---|---|
| PF | <0.001 | 0.075 | |||
| Follow-up | -0.8*10−2 (0.8*10−1) | -0.2; 0.2 | 0.922 | ||
| Gender | 1.5 (1.7) | -1.9; 4.9 | 0.401 | ||
| Age | -0.5 (0.1) | -0.7; -0.4 | <0.001 | ||
| <0.001 | 0.139 | ||||
| Amputation | 0.9 (6.3) | -11.4; 13.1 | 0.888 | ||
| Spinal cord injury | -9.1 (5.3) | -19.5; 1.3 | 0.087 | ||
| Brain injury | 18.5 (4.1) | 10.4; 26.6 | <0.001 | ||
| Chronic pain | 29.9 (4.3) | 21.5; 38.2 | <0.001 | ||
| Other neurological disability | 4.8 (5.2) | -5.3; 14.9 | 0.354 | ||
| Other | 16.9 (4.7) | 7.6; 26.1 | <0.001 | ||
| <0.001 | 0.064 | ||||
| Movement intensity | 0.2 (0.3) | -0.3; 0.7 | 0.439 | ||
| <0.001 | 0.020 | ||||
| Age * movement | 0.7*10−2 (0.3*10−2) | 0.2*10−2; 0.1*10−1 | 0.007 | ||
| Amputation * movement | -0.6 (0.3) | -1.1; -0.7*10−1 | 0.028 | ||
| Spinal cord injury * movement | -0.1 (0.3) | -0.6; 0.4 | 0.658 | ||
| Brain injury * movement | -0.2*10−1 (0.2) | -0.5; 0.5 | 0.942 | ||
| Chronic pain * movement | -0.3 (0.2) | -0.8; 0.2 | 0.200 | ||
| Other neurological disability * movement | -0.2 (0.3) | -0.8; 0.3 | 0.848 | ||
| Other * movement | |||||
| 55.8 (5.8) | 44.5; 67.1 | <0.001 | |||
| SF | 0.019 | 0.010 | |||
| Follow-up | 0.7*10−1 (0.8*10−1) | -0.1; 0.2 | 0.423 | ||
| Gender | -1.3 (1.7) | -4.6; 2.1 | 0.467 | ||
| Age | -0.2 (0.7*10−1) | -0.4; -0.7*10−1 | 0.004 | ||
| 0.005 | 0.013 | ||||
| Amputation | 7.0 (6.2) | -5.1; 19.1 | 0.257 | ||
| Spinal cord injury | 4.8 (5.2) | -5.4; 15.0 | 0.357 | ||
| Brain injury | -0.3 (4.1) | -8.4; 7.8 | 0.946 | ||
| Chronic pain | 8.3 (4.3) | -0.6*10−1; 16.7 | 0.052 | ||
| Other neurological disability | 9.2 (5.1) | -0.8; 19.3 | 0.072 | ||
| Other | 8.8 (4.7) | -0.4; 18.1 | 0.060 | ||
| <0.001 | 0.009 | ||||
| Movement intensity | 0.5*10−1 (0.3) | -0.5; 0.6 | 0.846 | ||
| <0.001 | 0.014 | ||||
| Age * movement | 0.6*10−2 (0.3*10−2) | 0.1*10−2; 0.1*10−1 | 0.022 | ||
| Amputation * movement | -0.5 (0.3) | -1.0; 0.8*10−1 | 0.094 | ||
| Spinal cord injury * movement | -0.2 (0.3) | -0.7; 0.3 | 0.402 | ||
| Brain injury * movement | -0.9*10−1 (0.2) | -0.6; 0.4 | 0.699 | ||
| Chronic pain * movement | -0.3 (0.2) | -0.8; 0.2 | 0.225 | ||
| Other neurological disability * movement | -0.2 (0.3) | -0.7; 0.3 | 0.486 | ||
| Other * movement | -0.3 (0.2) | -0.8; 0.2 | 0.243 | ||
| 67.2 (5.7) | 56.0; 78.5 | <0.001 | |||
| RP | 0.087 | 0.007 | |||
| Follow-up | 0.1 (0.1) | -0.1; 0.4 | 0.375 | ||
| Gender | -2.2 (2.7) | -7.5; 3.1 | 0.410 | ||
| Age | -0.1 (0.1) | -0.3; 0.6*10−1 | 0.165 | ||
| 0.343 | 0.004 | ||||
| Amputation | 5.3 (8.9) | -12.3; 22.9 | 0.554 | ||
| Spinal cord injury | 6.4 (7.5) | -8.4; 21.2 | 0.395 | ||
| Brain injury | 4.8 (5.8) | -6.5; 16.1 | 0.401 | ||
| Chronic pain | 4.2 (5.9) | -7.3; 15.7 | 0.472 | ||
| Other neurological disability | 0.5 (6.6) | -12.5; 13.4 | 0.946 | ||
| Other | 7.4 (6.4) | -5.7; 20.4 | 0.268 | ||
| 0.001 | 0.021 | ||||
| MET * hr/wk | 0.3 (0.1) | 0.2; 0.4 | <0.001 | ||
| 32.3 (8.3) | 22.0; 54.5 | <0.001 | |||
| RE | 0.088 | 0.007 | |||
| Follow-up | 0.2 (0.1) | -0.3*10−1; 0.5 | 0.084 | ||
| Gender | 0.9; 2.7 | -4.5; 6.3 | 0.744 | ||
| Age | -0.1 (0.1) | -0.3; 0.1 | 0.297 | ||
| 0.002 | 0.021 | ||||
| Amputation | -0.8 (10.4) | -21.2; 19.6 | 0.938 | ||
| Spinal cord injury | 5.4 (8.5) | -11.4; 22.1 | 0.528 | ||
| Brain injury | -10.2 (6.7) | -23.4; 2.9 | 0.127 | ||
| Chronic pain | 5.5 (6.8) | -8.0; 19.0 | 0.422 | ||
| Other neurological disability | 2.4 (8.2) | -13.7; 18.4 | 0.774 | ||
| Other | 3.9 (7.7) | -11.2; 18.9 | 0.615 | ||
| <0.001 | 0.006 | ||||
| Movement intensity | 0.2*10−1 (0.4) | -0.7; 0.7 | 0.957 | ||
| 0.004 | 0.003 | ||||
| Amputation * movement | 0.3 (0.5) | -0.6; 1.2 | 0.476 | ||
| Spinal cord injury * movement | 0.2*10−1 (0.4) | -0.8; 0.8 | 0.954 | ||
| Brain injury * movement | 0.2 (0.4) | -0.5; 1.0 | 0.546 | ||
| Chronic pain * movement | 0.3*10−1 (0.4) | -0.7; 0.8 | 0.945 | ||
| Other neurological disability * movement | 0.9*10−1 (0.4) | -0.7; 0.9 | 0.824 | ||
| Other * movement | 0.2 (0.4) | -0.6; 1.0 | 0.595 | ||
| 66.7 (8.8) | 49.4; 84.0 | <0.001 | |||
| MH | 0.598 | 0.002 | |||
| Follow-up | 0.6*10−1 (0.5*10−1) | -0.3*10−1; 0.2 | 0.189 | ||
| Gender | -0.7 (1.0) | -2.6; 1.3 | 0.502 | ||
| Age | 0.2*10−1 (0.4*10−1) | -0.5*10−1; 0.9*10−1 | 0.601 | ||
| 0.643 | 0.005 | ||||
| Amputation | 1.5 (3.2) | -4.7; 7.7 | 0.642 | ||
| Spinal cord injury | 1.2 (2.7) | -4.1; 6.4 | 0.668 | ||
| Brain injury | -1.0 (2.1) | -5.1; 3.1 | 0.632 | ||
| Chronic pain | 1.1 (2.1) | -3.1; 5.3 | 0.617 | ||
| Other neurological disability | 1.5 (2.4) | -3.3; 6.2 | 0.545 | ||
| Other | 1.3 (2.4) | -3.4; 6.1 | 0.578 | ||
| 0.190 | 0.007 | ||||
| Movement intensity | 0.6*10−1 (0.2*10−1) | 0.2*10−1; 0.1 | 0.010 | ||
| 61.1 (3.0) | 55.3; 67.0 | <0.001 | |||
| VT | 0.031 | 0.009 | |||
| Follow-up | 0.9*10−1 (0.5*10−1) | -0.9*10−2; 0.2 | 0.076 | ||
| Gender | 1.1 (1.1) | -0.9; 3.2 | 0.278 | ||
| Age | -0.2*10−1 (0.4*10−1) | -0.9*10−1; 0.5*10−1 | 0.623 | ||
| 0.004 | 0.015 | ||||
| Amputation | 9.5 (3.7) | 2.1; 16.9 | 0.011 | ||
| Spinal cord injury | 6.8 (3.2) | 0.6; 13.1 | 0.031 | ||
| Brain injury | 2.4 (2.5) | -2.5; 7.3 | 0.340 | ||
| Chronic pain | 2.7 (2.6) | -2.4; 7.8 | 0.299 | ||
| Other neurological disability | 4.3 (3.4) | -1.9; 10.4 | 0.176 | ||
| Other | 4.1 (2.9) | -1.5; 9.8 | 0.151 | ||
| <0.001 | 0.033 | ||||
| Movement intensity | 0.3 (0.1) | 0.3*10−1; 0.6 | 0.030 | ||
| <0.001 | 0.005 | ||||
| Amputation * movement | -0.2 (0.2) | -0.5; 0.2 | 0.317 | ||
| Spinal cord injury * movement | -0.2 (0.2) | -0.5; 0.9*10−1 | 0.167 | ||
| Brain injury * movement | -0.1 (0.1) | -0.4; 0.1 | 0.321 | ||
| Chronic pain * movement | -0.2 (0.1) | -0.5; 0.8*10−1 | 0.147 | ||
| Other neurological disability * movement | -0.8*10−1 (0.2) | -0.4; 0.2 | 0.603 | ||
| Other * movement | -0.9*10−1 (0.2) | -0.4; 0.2 | 0.554 | ||
| 44.0 (3.3) | 37.6; 50.4 | <0.001 | |||
| BP | 0.016 | 0.010 | |||
| Follow-up | 0.4*10−1 (0.8*10−1) | -0.1; 0.2 | 0.598 | ||
| Gender | 3.0 (1.7) | -0.3; 6.3 | 0.073 | ||
| Age | -0.7*10−1 (0.6*10−1) | -0.2; 0.4*10−1 | 0.218 | ||
| <0.001 | 0.063 | ||||
| Amputation | -0.7 (5.9) | -12.3; 11.0 | 0.910 | ||
| Spinal cord injury | -3.4 (5.0) | -13.2; 6.4 | 0.494 | ||
| Brain injury | 6.1 (4.0) | -1.7; 13.8 | 0.128 | ||
| Chronic pain | -11.1 (4.1) | -19.2; -3.1 | 0.007 | ||
| Other neurological disability | -3.9 (4.9) | -13.6; 5.7 | 0.426 | ||
| Other | -7.2 (4.5) | -16.1; 1.7 | 0.114 | ||
| <0.001 | 0.013 | ||||
| Movement intensity | 0.3 (0.2) | -0.2; 0.7 | 0.215 | ||
| <0.001 | 0.005 | ||||
| Amputation * movement | -0.3 (0.3) | -0.9; 0.2 | 0.200 | ||
| Spinal cord injury * movement | -0.3 (0.3) | -0.8; 0.2 | 0.293 | ||
| Brain injury * movement | -0.8*10−1 (0.2) | -0.5; 0.4 | 0.732 | ||
| Chronic pain * movement | -0.1 (0.2) | -0.6; 0.3 | 0.648 | ||
| Other neurological disability * movement | -0.2 (0.3) | -0.7; 0.3 | 0.415 | ||
| Other * movement | 0.4*10−1 (0.2) | -0.5; 0.4 | 0.874 | ||
| 65.7 (5.2) | 55.5; 75.9 | <0.001 | |||
| GH | 0.015 | 0.010 | |||
| Follow-up | 0.7*10−1 (0.6*10−1) | -0.5*10−1; 0.2 | 0.231 | ||
| Gender | -2.3 (1.3) | -4.9; 0.2 | 0.076 | ||
| Age | -0.7*10−1 (0.5*10−1) | -0.2; 0.2*10−1 | 0.113 | ||
| <0.001 | 0.035 | ||||
| Amputation | 8.2 (4.7) | -0.9; 17.4 | 0.078 | ||
| Spinal cord injury | 13.7 (3.9) | 6.0; 21.4 | 0.001 | ||
| Brain injury | 11.3 (3.1) | 5.2; 17.4 | <0.001 | ||
| Chronic pain | 13.4 (3.2) | 7.0; 19.7 | <0.001 | ||
| Other neurological disability | 7.0 (3.9) | -0.5; 14.6 | 0.069 | ||
| Other | 8.9 (3.6) | 1.9; 15.8 | 0.013 | ||
| <0.001 | 0.039 | ||||
| Movement intensity | 0.2 (0.2) | -0.2; 0.5 | 0.278 | ||
| <0.001 | 0.007 | ||||
| Amputation * movement | 0.3*10−1 (0.2) | -0.4; 0.4 | 0.894 | ||
| Spinal cord injury * movement | -0.1 (0.2) | -0.5; 0.3 | 0.609 | ||
| Brain injury * movement | 0.9*10−1 (0.2) | -0.3; 0.5 | 0.611 | ||
| Chronic pain * movement | -0.4*10−1 (0.2) | -0.4; 0.3 | 0.835 | ||
| Other neurological disability * movement | -0.1 (0.2) | -0.5; 0.3 | 0.549 | ||
| Other * movement | 0.1 (0.2) | -0.2; 0.5 | 0.489 | ||
| 43.4 (4.1) | 35.4; 51.5 | <0.001 | |||
| HC | <0.001 | 0.026 | |||
| Follow-up | -0.2 (0.9*10−1) | -0.4; -0.1*10−1 | 0.035 | ||
| Gender | -0.8 (1.5) | -3.8; 2.1 | 0.581 | ||
| Age | -0.2 (0.6*10−1) | -0.3; -0.8*10−1 | 0.001 | ||
| <0.001 | 0.025 | ||||
| Amputation | 16.9 (5.3) | 6.4; 27.4 | 0.002 | ||
| Spinal cord injury | 16.2 (4.5) | 7.3; 25.1 | <0.001 | ||
| Brain injury | 14.2 (3.6) | 7.2; 21.3 | <0.001 | ||
| Chronic pain | 16.7 (3.7) | 9.4; 23.9 | <0.001 | ||
| Other neurological disability | 10.9 (4.5) | 2.2; 19.7 | 0.014 | ||
| Other | 18.5 (4.1) | 10.5; 26.5 | <0.001 | ||
| <0.001 | 0.042 | ||||
| Movement intensity | 0.7 (0.3) | 0.2; 1.3 | 0.004 | ||
| <0.001 | 0.014 | ||||
| Follow up * movement | -0.6*10−2 (0.3*10−2) | -0.1*10−1; 0.1*10−2 | 0.075 | ||
| Age * movement | 0.4*10−2 (0.2*10−2) | <0.1*10−2; 0.9*10−2 | 0.078 | ||
| Amputation * movement | -0.6 (0.5) | -1.1; -0.2 | 0.009 | ||
| Spinal cord injury * movement | -0.5 (0.2) | -1.0; -0.6*10−1 | 0.026 | ||
| Brain injury * movement | -0.5 (0.2) | -0.9; -0.9*10−1 | 0.016 | ||
| Chronic pain * movement | -0.5 (0.2) | -0.9; -0.1 | 0.010 | ||
| Other neurological disability * movement | -0.5 (0.2) | -0.9; -0.2*10−1 | 0.043 | ||
| Other * movement | -0.6 (0.2) | -1.0; -0.2 | 0.007 | ||
| 48.9 (5.2) | 38.7; 59.1 | <0.001 |
a Follow-up in months
b Reference = female
c Age in years
d Reference = Multiple sclerosis
e Brain injuries from vascular, traumatic or oncological origin and meningitis
f Spina bifida, Parkinson’s Disease and Guillain-Barré Syndrome
g Disabilities such as tumors, fibromyalgia, arthritis, multi trauma, chronic fatigue syndrome and decubitus ulcer
h Movement intensity expressed as MET * hr/wk; PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change; SE = standard error; 95% CI = 95% confidence interval.
Fig 2Health related quality of life separated for different diagnosis groups.
Green solid line = amputation; green dotted line = spinal cord injury; blue solid line = brain injury; blue dotted line = multiple sclerosis; red solid line = chronic pain; red dotted line = other neurological disease; black line = other patients. Asterisks indicate significant differences between different diagnoses groups. PF = physical functioning; SF = social functioning; RP = role limitations–physical; RE = role limitations–emotional; MH = mental health; VT = vitality; BP = pain; GH = general health; HC = health change.